(EYE) National Vision Holdings - Overview

Sector: Consumer Cyclical | Industry: Specialty Retail | Exchange: NASDAQ (USA) | Market Cap: 2.057m USD | Total Return: 109% in 12m

Stock Eyeglasses, Contact Lenses, Eye Exams
Total Rating 45
Safety 59
Buy Signal -0.61
Specialty Retail +4.7
Other Specialty Retail -1.5
Market Cap: 2,057m
Avg Trading Vol: 36.4M USD
ATR: 6.23%
Peers RS (IBD): 76.7
Risk 5d forecast
Volatility49.3%
Rel. Tail Risk-10.3%
Reward TTM
Sharpe Ratio1.61
Alpha78.79
Character TTM
Beta1.344
Beta Downside2.140
Drawdowns 3y
Max DD64.01%
CAGR/Max DD0.19
EPS (Earnings per Share) EPS (Earnings per Share) of EYE over the last years for every Quarter: "2021-03": 0.48, "2021-06": 0.48, "2021-09": 0.38, "2021-12": 0.13, "2022-03": 0.33, "2022-06": 0.21, "2022-09": 0.15, "2022-12": -0.08, "2023-03": 0.31, "2023-06": 0.17, "2023-09": 0.15, "2023-12": -0.02, "2024-03": 0.32, "2024-06": 0.15, "2024-09": 0.12, "2024-12": -0.04, "2025-03": 0.34, "2025-06": 0.18, "2025-09": 0.13, "2025-12": 0.15, "2026-03": 0,
EPS CAGR: -26.73%
EPS Trend: -8.5%
Last SUE: -4.00
Qual. Beats: 0
Revenue Revenue of EYE over the last years for every Quarter: 2021-03: 534.18, 2021-06: 549.489, 2021-09: 518.005, 2021-12: 477.851, 2022-03: 527.711, 2022-06: 509.555, 2022-09: 499.207, 2022-12: 468.931, 2023-03: 520.797, 2023-06: 431.786, 2023-09: 438.82, 2023-12: 506.403, 2024-03: 482.794, 2024-06: 451.733, 2024-09: 451.515, 2024-12: 437.278, 2025-03: 510.324, 2025-06: 486.423, 2025-09: 487.33, 2025-12: 503.411, 2026-03: null,
Rev. CAGR: -1.25%
Rev. Trend: -18.5%
Last SUE: 0.33
Qual. Beats: 0
Risks
Technicals: choppy
Description: EYE National Vision Holdings

National Vision Holdings, Inc. (EYE) is a US-based optical retailer. The company operates through its Owned & Host and Legacy segments.

EYE sells eyeglasses, contact lenses, and optical accessories. It provides eye exams through various retail brands, including Americas Best and Eyeglass World. The optical retail sector is characterized by a mix of product sales and service provision (eye exams).

The company also offers health maintenance organization and optometric services. Its business model integrates retail sales with professional optometric services.

For more in-depth analysis, consider researching EYEs performance on ValueRay.

Headlines to Watch Out For
  • Americas Best and Eyeglass World store growth drives revenue
  • Walmart Vision Center contracts impact revenue and costs
  • Optometric services and eye exam demand influences sales
  • Contact lens sales contribute to overall revenue
  • Healthcare regulation changes affect operating costs
Piotroski VR‑10 (Strict) 4.5
Net Income: 29.6m TTM > 0 and > 6% of Revenue
FCF/TA: 0.03 > 0.02 and ΔFCF/TA 1.55 > 1.0
NWC/Revenue: -9.39% < 20% (prev -11.98%; Δ 2.59% < -1%)
CFO/TA 0.07 > 3% & CFO 146.3m > Net Income 29.6m
Net Debt (655.9m) to EBITDA (153.3m): 4.28 < 3
Current Ratio: 0.55 > 1.5 & < 3
Outstanding Shares: last quarter (81.8m) vs 12m ago 3.84% < -2%
Gross Margin: 56.47% > 18% (prev 0.58%; Δ 5.59k% > 0.5%)
Asset Turnover: 96.15% > 50% (prev 90.81%; Δ 5.33% > 0%)
Interest Coverage Ratio: 3.54 > 6 (EBITDA TTM 153.3m / Interest Expense TTM 16.9m)
Altman Z'' 0.23
A: -0.09 (Total Current Assets 225.7m - Total Current Liabilities 412.4m) / Total Assets 2.13b
B: 0.12 (Retained Earnings 255.7m / Total Assets 2.13b)
C: 0.03 (EBIT TTM 60.0m / Avg Total Assets 2.07b)
D: 0.20 (Book Value of Equity 256.5m / Total Liabilities 1.26b)
Altman-Z'' Score: 0.23 = B
Beneish M -2.88
DSRI: 1.05 (Receivables 57.3m/49.9m, Revenue 1.99b/1.82b)
GMI: 1.03 (GM 56.47% / 58.10%)
AQI: 1.11 (AQ_t 0.55 / AQ_t-1 0.49)
SGI: 1.09 (Revenue 1.99b / 1.82b)
TATA: -0.05 (NI 29.6m - CFO 146.3m) / TA 2.13b)
Beneish M-Score: -2.88 (Cap -4..+1) = A
What is the price of EYE shares? As of April 05, 2026, the stock is trading at USD 25.90 with a total of 1,398,592 shares traded.
Over the past week, the price has changed by -5.77%, over one month by -11.04%, over three months by -9.30% and over the past year by +109.00%.
Is EYE a buy, sell or hold? National Vision Holdings has received a consensus analysts rating of 4.09. Therefore, it is recommended to buy EYE.
  • StrongBuy: 6
  • Buy: 0
  • Hold: 5
  • Sell: 0
  • StrongSell: 0
What are the forecasts/targets for the EYE price?
Wallstreet Target Price 35.3 36.2%
Analysts Target Price 35.3 36.2%
EYE Fundamental Data Overview as of 01 April 2026
P/E Trailing = 70.0
P/E Forward = 26.738
P/S = 1.0352
P/B = 2.2501
Revenue TTM = 1.99b USD
EBIT TTM = 60.0m USD
EBITDA TTM = 153.3m USD
Long Term Debt = 223.2m USD (from longTermDebt, last quarter)
Short Term Debt = 106.9m USD (from shortTermDebt, last quarter)
Debt = 694.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 655.9m USD (from netDebt column, last quarter)
Enterprise Value = 2.71b USD (2.06b + Debt 694.6m - CCE 38.7m)
Interest Coverage Ratio = 3.54 (Ebit TTM 60.0m / Interest Expense TTM 16.9m)
EV/FCF = 36.94x (Enterprise Value 2.71b / FCF TTM 73.5m)
FCF Yield = 2.71% (FCF TTM 73.5m / Enterprise Value 2.71b)
FCF Margin = 3.70% (FCF TTM 73.5m / Revenue TTM 1.99b)
Net Margin = 1.49% (Net Income TTM 29.6m / Revenue TTM 1.99b)
Gross Margin = 56.47% ((Revenue TTM 1.99b - Cost of Revenue TTM 865.1m) / Revenue TTM)
Gross Margin QoQ = 53.48% (prev 53.75%)
Tobins Q-Ratio = 1.28 (Enterprise Value 2.71b / Total Assets 2.13b)
Interest Expense / Debt = 0.58% (Interest Expense 4.04m / Debt 694.6m)
Taxrate = 28.98% (12.1m / 41.7m)
NOPAT = 42.6m (EBIT 60.0m * (1 - 28.98%))
Current Ratio = 0.55 (Total Current Assets 225.7m / Total Current Liabilities 412.4m)
Debt / Equity = 0.80 (Debt 694.6m / totalStockholderEquity, last quarter 869.5m)
Debt / EBITDA = 4.28 (Net Debt 655.9m / EBITDA 153.3m)
Debt / FCF = 8.93 (Net Debt 655.9m / FCF TTM 73.5m)
Total Stockholder Equity = 853.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.43% (Net Income 29.6m / Total Assets 2.13b)
RoE = 3.47% (Net Income TTM 29.6m / Total Stockholder Equity 853.8m)
RoCE = 5.57% (EBIT 60.0m / Capital Employed (Equity 853.8m + L.T.Debt 223.2m))
RoIC = 3.77% (NOPAT 42.6m / Invested Capital 1.13b)
WACC = 8.11% (E(2.06b)/V(2.75b) * Re(10.71%) + D(694.6m)/V(2.75b) * Rd(0.58%) * (1-Tc(0.29)))
Discount Rate = 10.71% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.22%
[DCF] Terminal Value 81.23% ; FCFF base≈59.3m ; Y1≈73.2m ; Y5≈124.9m
[DCF] Fair Price = 18.15 (EV 2.10b - Net Debt 655.9m = Equity 1.44b / Shares 79.4m; r=8.11% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -8.49 | EPS CAGR: -26.73% | SUE: -4.0 | # QB: 0
Revenue Correlation: -18.55 | Revenue CAGR: -1.25% | SUE: 0.33 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.21 | Chg7d=+0.001 | Chg30d=-0.009 | Revisions Net=-4 | Analysts=12
EPS current Year (2026-12-31): EPS=0.99 | Chg7d=+0.001 | Chg30d=+0.063 | Revisions Net=+7 | Growth EPS=+23.7% | Growth Revenue=+4.4%
EPS next Year (2027-12-31): EPS=1.25 | Chg7d=+0.000 | Chg30d=+0.100 | Revisions Net=+4 | Growth EPS=+26.7% | Growth Revenue=+6.6%
[Analyst] Revisions Ratio: -0.50 (2 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.3% (Discount Rate 10.7% - Earnings Yield 1.4%)
[Growth] Growth Spread = -4.5% (Analyst 4.8% - Implied 9.3%)
External Resources
Dataroma Stockcircle